Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Treasury Shares (2021 - 2025)

GeneDx Holdings (WGS) has disclosed Treasury Shares for 5 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 18.71% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 18.71% decrease, with the full-year FY2025 number at $1.5 million, down 18.71% from a year prior.
  • Treasury Shares was $1.5 million for Q4 2025 at GeneDx Holdings, down from $1.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $23.7 million in Q3 2022 to a low of $855061.0 in Q4 2022.
  • A 5-year average of $5.5 million and a median of $1.9 million in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: plummeted 93.21% in 2022, then skyrocketed 76.35% in 2023.
  • GeneDx Holdings' Treasury Shares stood at $12.6 million in 2021, then tumbled by 93.21% to $855061.0 in 2022, then surged by 76.35% to $1.5 million in 2023, then increased by 23.99% to $1.9 million in 2024, then dropped by 18.71% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Treasury Shares are $1.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025).